LN

Lakshmipriya Naha Biswas

Active Director Director DIN 08956064
DIN 08956064 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmipriya Naha Biswas

Data last updated:

Lakshmipriya Naha Biswas is a Director at Cepheus Lifesciences Private Limited (since 2020). The company operates in Pharma.

DIN 08956064
Primary Designation Director
Industry Pharma
First Appointment 10 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cepheus Lifesciences Private Limited U85320WB2020PTC241198
Director10 Nov 20202020Active

Board colleagues of Lakshmipriya Naha Biswas

Directorship timeline

Open interactive timeline →
Cepheus Lifesciences Private Limited
Premium access

Shareholding and investment profile for Lakshmipriya Naha Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmipriya Naha Biswas

Lakshmipriya Naha Biswas currently holds 1 directorship: Cepheus Lifesciences Private Limited (Director, since 10 Nov 2020).

Lakshmipriya Naha Biswas was first appointed on 10 Nov 2020 as Director at Cepheus Lifesciences Private Limited.

The current boards of Lakshmipriya Naha Biswas's companies include Kaushik Naha Biswas (Cepheus Lifesciences Private Limited), Prashant Shukla (Cepheus Lifesciences Private Limited), Satish Kumar Shukla (Cepheus Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available